Comparison of inflammatory control and safety by timing of doxycycline-azithromycin dual therapy in pediatric mycoplasmal pneumonia
Pak J Pharm Sci. 2025 Nov-Dec;38(6):2264-2270. doi: 10.36721/PJPS.2025.38.6.REG.14009.1. ABSTRACT The therapeutic approach of combining doxycycline (DOX) with azithromycin (AZM) has emerged as an effective strategy …